314.8000.91% ( +2.830 )
Trading: Oct 8, 15:17:30 (EDT)Current ValuationThe current P/E ratio is 25.24, below the reasonable range, cheaper than 81.48% of the time in the past 3 years, and the industry ranks 15/74, the industry Median --.
25.24xP/E
$311.97Stock price
$12.36Earnings per share
25.24xP/E
Stock price$311.97Earnings per share$12.36
Historical Valuation
P/E ratioTypical rangeMedian
- P/E ratio
- 29.06x
- Typical range
- 25.36x–42.66x
Peer P/E ratio Comparison
It displays how the company's P/E ratio compares to top companies within its industry.
07142128
The industry median valuation is currently at or below 0 and may not serve as a meaningful benchmark.
Industry P/E ratio Comparison
This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
0x30x60x90x120x150x
| Name/Symbol | |||
|---|---|---|---|
CVSUSCVS Health | 23.00x | 394.45% | $112.49B |
LHUSLabcorp | 25.24x | 33.20% | $25.30B |
DGXUSQuest Diagnostics | 23.69x | 16.18% | $25.06B |
CHEUSChemed | 26.65x | 26.94% | $7.33B |
OPCHUSOption Care Health | 22.16x | 18.20% | $4.64B |
ADUSUSAddus Homecare | 20.09x | 18.27% | $2.12B |
VMDUSViemed Healthcare | 24.62x | 11.71% | $356.89M |
Risk Warning
Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.
